01406nam a2200301 a 4500001001200000003000800012006001900020007001500039008004100054020001800095020001500113040002100128035002100149050002500170100001800195245025600213260005700469300001400526504005300540533015200593650002500745655002900770700001800799700002400817710012000841710001700961856012600978ebr10443278CaPaEBRm        u        cr cn|||||||||110215s2011    dcu     sb    000 0 eng d  z9780309163248  z0309163242  aCaPaEBRcCaPaEBR  a(OCoLC)70792732314aR853.B54bM33 2011eb1 aMack, Alison.10aPerspectives on biomarker and surrogate endpoint evaluationh[electronic resource] :bdiscussion forum summary /cAlison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.  aWashington, D.C. :bNational Academies Press,c2011.  ax, 129 p.  aIncludes bibliographical references (p. 99-102).  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aBiochemical markers. 7aElectronic books.2local1 aBalogh, Erin.1 aMicheel, Christine.2 aInstitute of Medicine (U.S.).bCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10443278zAn electronic book accessible through the World Wide Web; click to view